![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
20
Ipca Laboratories Limited Mumbai In, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their significant offerings is Tramadol hydrochloride, YT3 process, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2011-085 - Rev 00
This Chemical Type CEP, issued on August 04, 2016, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 1681 associated with this CEP further emphasizes